{
  "num_tested_probands": [
    2,
    6,
    7,
    1,
    0,
    2,
    null,
    0
  ],
  "num_positive_het_probands": [
    0,
    0,
    4,
    0,
    0,
    0,
    null,
    0
  ],
  "positive_phenotypes": [
    [
      "moderate intellectual disability",
      "microcephaly",
      "ataxia",
      "speech impairment",
      "aggressive behavior"
    ],
    [],
    [
      "intellectual disability (ID)",
      "speech impairment",
      "aggressive behavior",
      "microcephaly",
      "ataxia",
      "muscular weakness",
      "tonic-clonic seizures"
    ],
    [
      "Intellectual Disability (ID)"
    ],
    [],
    [
      "moderate ID",
      "speech impairment",
      "seizures",
      "ataxia",
      "muscular weakness"
    ],
    [
      "neurodevelopmental and neurodegenerative phenotype",
      "infantile hepatopathy",
      "recessive intermediate CMT disease type B",
      "self-abusive behavior",
      "developmental delay"
    ],
    []
  ],
  "num_compound_or_double_hets": [
    1,
    0,
    0,
    0,
    1,
    2,
    null,
    0
  ],
  "quote_snippets": [
    [
      [
        "In the first family, we identified a homozygous missense mutation (c.514G>A,pAsp172Asn) in the cytoplasmic seryl-tRNA synthetase (SARS) gene."
      ],
      [
        "Inthesecond family, we found compound DNA-alterations affecting the mitochondrial tryptophanyl-tRNA synthetase (WARS2) gene"
      ],
      [
        "revealed a homozygous missense mutation in the Seryl-tRNA Synthetase (SARS) gene (MIM# 607529), which co-segregates with moderate ID; microcephaly, ataxia, speech impairment; and aggres- sive behavior:"
      ],
      [
        "we found compound DNA-alterations affecting the mitochondrial tryptophanyl-tRNA synthetase (WARS2) gene (MIM# 604733) by whole genome sequencing and could show that both co-segregate with moderate ID, ataxia, speech impairment; microcephaly, andaggressive behavior:"
      ]
    ],
    [
      "Family 2 was part of a large study of the molecular basis of ARID and genotyping results of six DNA samples (IV.2, IV:3, V.2, V:7 V:8, V:9) from this family were used for homozygosity mapping and multipoint parametric and non-parametric linkage analysis."
    ],
    [
      [
        "Family 1 is an Iranian family with Arabian ethnicity: The distantly related parents had nine children, four of them presented with ID;",
        "the pedigree is shown in Figure 1A All affected children were born at full term after uneventful pregnancies, followed by a normal neonatal period:"
      ],
      [
        "Testing of cognitive function using the Wechsler Adult Intelli-",
        "gence Scale (WAIS-IV) showed an intelligence quotient (IQ) 40-45 in the range of moderate ID; speech impairment (slow and slurred speech) and aggressive behavior:"
      ],
      [
        "In addition, the patients presented with microcephaly, ataxia (unbalanced gait starting at the age of 7-",
        "10 years) , and muscular weakness (since the age of 6-10)."
      ],
      [
        "All patients developed tonic-clonic seizures during infancy, which are well con-",
        "trolled by sodium valproate:"
      ],
      [
        "Family 2 is an Iranian family from the Semnan province of Iran: The consanguineous healthy parents had nine children, three of them with ID (Fig: 1B) One affected male (V:6) had died from an infectious dis-",
        "ease:"
      ],
      [
        "Twwo affected siblings (V:7 and V:8) presented with moderate ID (IQ = 41-46), athetosis, aggressive behavior; and speech impairment (slow and slurred speech):"
      ],
      [
        "Moreover muscular weakness and ataxia (unbalanced gait = starting at the age of 7-10 years) were observed (see",
        "Table 2):"
      ]
    ],
    [
      [
        "Full symbols represent affected individuals with ID.",
        "Arrows indicate the respective index patients."
      ]
    ],
    [
      [
        "As a result of whole genome sequencing; we found a com-",
        "pound het- erozygous genotype of the WARS2 gene in the affected individuals of family 2 (Fig: 1B and D)"
      ]
    ],
    [
      "In the second family, whole genome sequencing revealed a com-",
      "pound heterozygous genotype in affected individuals, consisting of a deleterious frame-shift mutation and a missense change (p Trp13Gly) in the mitochondrial tryptophanyl-tRNA synthetase encoding WARS2",
      "In this report; we describe putatively ID causing mutations in SARS and WARS2 in families with closely overlapping additional clinical features including moderate ID, speech impairment; seizures, ataxia, and mus-",
      "cular weakness."
    ],
    [
      "neurodevelopmental and neurodegenerative phenotype in mice; affecting the cerebral cor-",
      "tex and the hippocampus, particularly the parvalbumin (PV)-positive interneuron population",
      "Similar disease mechanisms have been proposed for mutations within LARS, which are associated with infantile hepatopathy",
      "mutations within KARSthat cause recessive intermediate CMT dis-",
      "ease type B (CMTRIB) (MIM# 613641) (McLaughlin et al,,2010) with a phenotype that does not only comprise peripheral neuropathy but also",
      "self-abusive behavior and developmental delay"
    ],
    []
  ],
  "cleaned_quotes": [
    [
      [
        "In the first family, we identified a homozygous missense mutation (c.514G>A, pAsp172Asn) in the cytoplasmic seryl-tRNA synthetase (SARS) gene."
      ],
      [
        "In the second family, we found compound DNA-alterations affecting the mitochondrial tryptophanyl-tRNA synthetase (WARS2) gene"
      ],
      [
        "revealed a homozygous missense mutation in the Seryl-tRNA Synthetase (SARS) gene (MIM# 607529), which co-segregates with moderate ID; microcephaly, ataxia, speech impairment; and aggressive behavior:"
      ],
      [
        "we found compound DNA-alterations affecting the mitochondrial tryptophanyl-tRNA synthetase (WARS2) gene (MIM# 604733) by whole genome sequencing and could show that both co-segregate with moderate ID, ataxia, speech impairment; microcephaly, and aggressive behavior:"
      ]
    ],
    [
      "Family 2 was part of a large study of the molecular basis of ARID and genotyping results of six DNA samples (IV.2, IV:3, V.2, V:7 V:8, V:9) from this family were used for homozygosity mapping and multipoint parametric and non-parametric linkage analysis."
    ],
    [
      [
        "Family 1 is an Iranian family with Arabian ethnicity: The distantly related parents had nine children, four of them presented with ID,",
        "the pedigree is shown in Figure 1A All affected children were born at full term after uneventful pregnancies, followed by a normal neonatal period."
      ],
      [
        "Testing of cognitive function using the Wechsler Adult Intelli-",
        "gence Scale (WAIS-IV) showed an intelligence quotient (IQ) 40-45 in the range of moderate ID, speech impairment (slow and slurred speech) and aggressive behavior."
      ],
      [
        "In addition, the patients presented with microcephaly, ataxia (unbalanced gait starting at the age of 7-",
        "10 years), and muscular weakness (since the age of 6-10)."
      ],
      [
        "All patients developed tonic-clonic seizures during infancy, which are well con-",
        "trolled by sodium valproate."
      ],
      [
        "Family 2 is an Iranian family from the Semnan province of Iran, the consanguineous healthy parents had nine children, three of them with ID (Fig: 1B) One affected male (V:6) had died from an infectious dis-",
        "ease."
      ],
      [
        "Twwo affected siblings (V:7 and V:8) presented with moderate ID (IQ = 41-46), athetosis, aggressive behavior, and speech impairment (slow and slurred speech)."
      ],
      [
        "Moreover muscular weakness and ataxia (unbalanced gait = starting at the age of 7-10 years) were observed (see",
        "Table 2)."
      ]
    ],
    [
      "Full symbols represent affected individuals with ID.",
      "Arrows indicate the respective index patients."
    ],
    [
      "As a result of whole genome sequencing; we found a com-",
      "pound heterozygous genotype of the WARS2 gene in the affected individuals of family 2 (Fig: 1B and D)"
    ],
    [
      "In the second family, whole genome sequencing revealed a com-",
      "pound heterozygous genotype in affected individuals, consisting of a deleterious frame-shift mutation and a missense change (p Trp13Gly) in the mitochondrial tryptophanyl-tRNA synthetase encoding WARS2",
      "In this report, we describe putatively ID causing mutations in SARS and WARS2 in families with closely overlapping additional clinical features including moderate ID, speech impairment, seizures, ataxia, and mus-",
      "cular weakness."
    ],
    [
      "neurodevelopmental and neurodegenerative phenotype in mice; affecting the cerebral cor-",
      "tex and the hippocampus, particularly the parvalbumin (PV)-positive interneuron population",
      "Similar disease mechanisms have been proposed for mutations within LARS, which are associated with infantile hepatopathy",
      "mutations within KARS that cause recessive intermediate CMT dis-",
      "ease type B (CMTRIB) (MIM# 613641) (McLaughlin et al, 2010) with a phenotype that does not only comprise peripheral neuropathy but also",
      "self-abusive behavior and developmental delay"
    ],
    []
  ],
  "gene_symbol": [
    [
      "AIMP1",
      "AR",
      "ARC",
      "GC",
      "L12",
      "MET",
      "PC",
      "SI",
      "TG",
      "TH",
      "TRO",
      "WARS2"
    ],
    [
      "AR",
      "GC",
      "P138",
      "TG",
      "WARS2"
    ],
    [
      "AR",
      "BL2",
      "DAP",
      "EGF",
      "HR",
      "L21",
      "LSM7",
      "PC",
      "SDHA",
      "SDS",
      "SP6",
      "TG",
      "WARS2"
    ],
    [
      "AR",
      "CIT",
      "GC",
      "P65",
      "PC",
      "S3A",
      "SI",
      "SP6",
      "WARS2",
      "ZNF697"
    ],
    [
      "AR",
      "PHB1",
      "S3A",
      "SDHA",
      "SDS",
      "SP6",
      "WARS2"
    ],
    [
      "AIMP1",
      "AR",
      "DAP",
      "DARS2",
      "ERG",
      "HPS6",
      "ISCU",
      "PHB1",
      "SDHA",
      "SDS",
      "SI",
      "SP6",
      "WARS2"
    ],
    [
      "AIMP1",
      "AR",
      "CARS2",
      "FER",
      "HR",
      "MCPH1",
      "MP1",
      "MTR",
      "NTS",
      "REN",
      "S18",
      "ST3GAL3",
      "TAT",
      "WARS2"
    ],
    [
      "AR",
      "EMB",
      "FAS",
      "IARS2",
      "NARS2",
      "PARS2",
      "POR",
      "WARS2"
    ]
  ],
  "genomic_hgvs": [
    [],
    [],
    [],
    [],
    [],
    [],
    [],
    []
  ],
  "explanation": {
    "num_tested_probands": [
      "There are reports on two unrelated Iranian families, each with an affected proband.",
      "Family 2 was part of a large study of the molecular basis of ARID and genotyping results of six DNA samples (IV.2, IV:3, V.2, V:7 V:8, V:9) from this family were used.",
      "Family 1 and Family 2 have a total of 9 children each, several of whom were affected and genotyped as part of the study.",
      "The proband highlighted in the study appears to be from family 1, index patient mentioned in Figure 1.",
      "The text does not specify the number of individual probands tested.",
      "The text mentions 'the second family' indicating two families with affected individuals.",
      "The text does not specify the number of probands tested.",
      "The document primarily lists references, and there's no indication in the provided text regarding the number of probands tested."
    ],
    "num_positive_het_probands": [
      "There is no mention of any proband who was heterozygous for a pathogenic variant; only homozygous and compound heterozygous cases are described.",
      "No positive heterozygous probands were mentioned in the report.",
      "Family 1 has 4 affected children tested positive for the symptoms described.",
      "The text does not mention any probands who tested positive as heterozygous for a pathogenic variant.",
      "There is no mention of probands who were heterozygous for a pathogenic variant.",
      "There is no specific mention of positive heterozygous probands in the text.",
      "The text does not specify the number of heterozygous probands.",
      "No specific proband heterozygosity results were mentioned in the provided text."
    ],
    "positive_phenotypes": [
      "The phenotypes associated with positive probands include moderate ID, microcephaly, ataxia, speech impairment, and aggressive behavior as a common phenotype between both families.",
      "No specific phenotypes were associated with positive probands in the report.",
      "Phenotypes for the affected individuals of Family 1 include ID, speech impairment, and ataxia.",
      "The phenotype Intellectual Disability (ID) is associated with affected individuals as noted in Figure 1.",
      "No clinical phenotypes associated with positive probands are mentioned.",
      "The text describes 'closely overlapping additional clinical features including moderate ID, speech impairment; seizures, ataxia, and muscular weakness.'",
      "Includes descriptions such as 'neurodevelopmental and neurodegenerative phenotype in mice', 'infantile hepatopathy', 'recessive intermediate CMT disease type B', 'self-abusive behavior', and 'developmental delay'.",
      "The text does not describe specific phenotypes associated with positive probands."
    ],
    "num_compound_or_double_hets": [
      "The second family has a compound heterozygous genotype involving the WARS2 gene.",
      "The report does not mention any individuals being compound or double heterozygotes.",
      "There is no mention of compound or double heterozygous mutations in the described families.",
      "There is no mention of compound or double heterozygous mutations in individuals.",
      "The text mentions a compound heterozygous mutation in the WARS2 gene in family 2.",
      "The report identifies a 'compound heterozygous genotype in affected individuals' in WARS2.",
      "The text does not specify the number of compound or double heterozygotes.",
      "There are mentions of compound heterozygosity in references, but this specific section has no quantifiable data about the number of compound or double heterozygotes."
    ]
  }
}